Deletion of cannabinoid receptors 1 and 2 exacerbates APC function to increase inflammation and cellular immunity during influenza infection

Journal of Leukocyte Biology

Volumn 90, Issue 5, 2011, Pages 983-995

  Karmaus, Peer W F ^a   Chen, Weimin ^a,b   Crawford, Robert B ^a   Harkema, Jack R ^a   Kaplan, Barbara L F ^a,c   Kaminski, Norbert E ^a,c  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b Michigan State University   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Endocannabinoids; Host response; Immune homeostasis; Immune regulation; Lung; Pathology

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CYTOKINE; TRANSCRIPTOME;

ABSENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL INFILTRATION; CELL ISOLATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; EFFECTOR CELL; HOMEOSTASIS; IMMUNE RESPONSE; IMMUNOREACTIVITY; IN VITRO STUDY; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; INFLUENZA; LUNG INJURY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGEN-PRESENTING CELLS; DENDRITIC CELLS; GENE DELETION; IMMUNITY, CELLULAR; LYMPHOCYTE ACTIVATION; MICE; ORTHOMYXOVIRIDAE INFECTIONS; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

MUS;

EID: 80055070153     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0511219     Document Type: Article

References (54)

1. Holt, P. G., Strickland, D. H., Wikstrom, M. E., Jahnsen, F. L. (2008) Regulation of immunological homeostasis in the respiratory tract. Nat. Rev. Immunol. 8, 142-152.
2. Kobayashi, K. S., Flavell, R. A. (2004) Shielding the double-edged sword: negative regulation of the innate immune system. J. Leukoc. Biol. 75, 428-433.
3. Wong, P., Pamer, E. G. (2003) Feedback regulation of pathogen-specific T cell priming. Immunity 18, 499-511.
4. Strieter, R. M., Belperio, J. A., Keane, M. P. (2002) Cytokines in innate host defense in the lung. J. Clin. Invest. 109, 699-705.
5. Banchereau, J., Steinman, R. M. (1998) Dendritic cells and the control of immunity. Nature 392, 245-252.
6. Doherty, P. C., Topham, D. J., Tripp, R. A., Cardin, R. D., Brooks, J. W., Stevenson, P. G. (1997) Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections. Immunol. Rev. 159, 105-117.
7. Kolls, J. K., Linden, A. (2004) Interleukin-17 family members and inflammation. Immunity 21, 467-476.
8. Korn, T., Bettelli, E., Oukka, M., Kuchroo, V. K. (2009) IL-17 and Th17 cells. Annu. Rev. Immunol. 27, 485-517.
9. Ye, P., Rodriguez, F. H., Kanaly, S., Stocking, K. L., Schurr, J., Schwarzenberger, P., Oliver, P., Huang, W., Zhang, P., Zhang, J., Shellito, J. E., Bagby, G. J., Nelson, S., Charrier, K., Peschon, J. J., Kolls, J. K. (2001) Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J. Exp. Med. 194, 519-527.
10. Kohlmeier, J. E., Woodland, D. L. (2009) Immunity to respiratory viruses. Annu. Rev. Immunol. 27, 61-82.
11. Crowe, C. R., Chen, K., Pociask, D. A., Alcorn, J. F., Krivich, C., Enelow, R. I., Ross, T. M., Witztum, J. L., Kolls, J. K. (2009) Critical role of IL-17RA in immunopathology of influenza infection. J. Immunol. 183, 5301-5310.
12. Wiley, J. A., Cerwenka, A., Harkema, J. R., Dutton, R. W., Harmsen, A. G. (2001) Production of interferon-γ by influenza hemagglutinin-specific CD8 effector T cells influences the development of pulmonary immunopathology. Am. J. Pathol. 158, 119-130.
13. Moskophidis, D., Kioussis, D. (1998) Contribution of virus-specific CD8+ cytotoxic T cells to virus clearance or pathologic manifestations of influenza virus infection in a T cell receptor transgenic mouse model. J. Exp. Med. 188, 223-232.
14. Di Marzo, V. (2008) Targeting the endocannabinoid system: to enhance or reduce? Nat. Rev. Drug Discov. 7, 438-455.
15. Bouaboula, M., Rinaldi, M., Carayon, P., Carillon, C., Delpech, B., Shire, D., Le Fur, G., Casellas, P. (1993) Cannabinoid-receptor expression in human leukocytes. Eur. J. Biochem. 214, 173-180.
16. Galiègue, S., Mary, S., Marchand, J., Dussossoy, D., Carriere, D., Carayon, P., Bouaboula, M., Shire, D., Le Fur, G., Casellas, P. (1995) Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur. J. Biochem. 232, 54-61.
17. Pandey, R., Mousawy, K., Nagarkatti, M., Nagarkatti, P. (2009) Endocannabinoids and immune regulation. Pharmacol. Res. 60, 85-92.
18. Karsak, M., Gaffal, E., Date, R., Wang-Eckhardt, L., Rehnelt, J., Petrosino, S., Starowicz, K., Steuder, R., Schlicker, E., Cravatt, B., Mechoulam, R., Buettner, R., Werner, S., Di Marzo, V., Tuting, T., Zimmer, A. (2007) Attenuation of allergic contact dermatitis through the endocannabinoid system. Science 316, 1494-1497.
19. Buchweitz, J. P., Karmaus, P. W., Williams, K. J., Harkema, J. R., Kaminski, N. E. (2008) Targeted deletion of cannabinoid receptors CB1 and CB2 produced enhanced inflammatory responses to influenza A/PR/ 8/34 in the absence and presence of {increment}9-tetrahydrocannabinol. J. Leukoc. Biol. 83, 785-796.
20. He, D., Wu, L., Kim, H. K., Li, H., Elmets, C. A., Xu, H. (2009) IL-17 and IFN-γ mediate the elicitation of contact hypersensitivity responses by different mechanisms and both are required for optimal responses. J. Immunol. 183, 1463-1470.
21. Hennet, T., Ziltener, H. J., Frei, K., Peterhans, E. (1992) A kinetic study of immune mediators in the lungs of mice infected with influenza A virus. J. Immunol. 149, 932-939.
22. Kaplan, B. L., Lawver, J. E., Karmaus, P. W., Ngaotepprutaram, T., Birmingham, N. P., Harkema, J. R., Kaminski, N. E. (2010) The effects of targeted deletion of cannabinoid receptors CB1 and CB2 on intranasal sensitization and challenge with adjuvant-free ovalbumin. Toxicol. Pathol. 38, 382-392.
23. Eisen, M. B., Spellman, P. T., Brown, P. O., Botstein, D. (1998) Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 95, 14863-14868.
24. Lutz, M. B., Kukutsch, N., Ogilvie, A. L., Rossner, S., Koch, F., Romani, N., Schuler, G. (1999) An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223, 77-92.
25. Brandt, K., Bulfone-Paus, S., Foster, D. C., Ruckert, R. (2003) Interleukin-21 inhibits dendritic cell activation and maturation. Blood 102, 4090-4098.
26. Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., Littman, D. R. (2006) The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126, 1121-1133.
27. Gonzalez-Juarrero, M., Shim, T. S., Kipnis, A., Junqueira-Kipnis, A. P., Orme, I. M. (2003) Dynamics of macrophage cell populations during murine pulmonary tuberculosis. J. Immunol. 171, 3128-3135.
28. Akira, S., Uematsu, S., Takeuchi, O. (2006) Pathogen recognition and innate immunity. Cell 124, 783-801.
29. Springs, A. E., Karmaus, P. W., Crawford, R. B., Kaplan, B. L., Kaminski, N. E. (2008) Effects of targeted deletion of cannabinoid receptors CB1 and CB2 on immune competence and sensitivity to immune modulation by {increment}9-tetrahydrocannabinol. J. Leukoc. Biol. 84, 1574-1584.
30. Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., Mechoulam, R., Pertwee, R. G. (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 54, 161-202.
31. Cabral, G.A., Staab, A. (2005) Effects on the immune system. Handb. Exp. Pharmacol., 385-423.
32. Beck-Schimmer, B., Schwendener, R., Pasch, T., Reyes, L., Booy, C., Schimmer, R. C. (2005) Alveolar macrophages regulate neutrophil recruitment in endotoxin-induced lung injury. Respir. Res. 6, 61.
33. Nathan, C. (2006) Neutrophils and immunity: challenges and opportunities. Nat. Rev. Immunol. 6, 173-182.
34. Wang, S. Z., Rosenberger, C. L., Bao, Y. X., Stark, J. M., Harrod, K. S. (2003) Clara cell secretory protein modulates lung inflammatory and immune responses to respiratory syncytial virus infection. J. Immunol. 171, 1051-1060.
35. Sandoval-Montes, C., Santos-Argumedo, L. (2005) CD38 is expressed selectively during the activation of a subset of mature T cells with reduced proliferation but improved potential to produce cytokines. J. Leukoc. Biol. 77, 513-521.
36. Cox, C. A., Shi, G., Yin, H., Vistica, B. P., Wawrousek, E. F., Chan, C. C., Gery, I. (2008) Both Th1 and Th17 are immunopathogenic but differ in other key biological activities. J. Immunol. 180, 7414-7422.
37. Chang, M., Lee, A. J., Fitzpatrick, L., Zhang, M., Sun, S. C. (2009) NF-κ B1 p105 regulates T cell homeostasis and prevents chronic inflammation. J. Immunol. 182, 3131-3138.
38. Jenner, R. G., Young, R. A. (2005) Insights into host responses against pathogens from transcriptional profiling. Nat. Rev. Microbiol. 3, 281-294.
39. Ludwiczek, S., Aigner, E., Theurl, I., Weiss, G. (2003) Cytokine-mediated regulation of iron transport in human monocytic cells. Blood 101, 4148-4154.
40. Kim, S., Ponka, P. (2000) Effects of interferon-γ and lipopolysaccharide on macrophage iron metabolism are mediated by nitric oxide-induced degradation of iron regulatory protein 2. J. Biol. Chem. 275, 6220-6226.
41. McCoy, K. L., Gainey, D., Cabral, G. A. (1995) {increment}9-Tetrahydrocannabinol modulates antigen processing by macrophages. J. Pharmacol. Exp. Ther. 273, 1216-1223.
42. McCoy, K. L., Matveyeva, M., Carlisle, S. J., Cabral, G. A. (1999) Cannabinoid inhibition of the processing of intact lysozyme by macrophages: evidence for CB2 receptor participation. J. Pharmacol. Exp. Ther. 289, 1620-1625.
43. Buckley, N. E., McCoy, K. L., Mezey, E., Bonner, T., Zimmer, A., Felder, C. C., Glass, M. (2000) Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor. Eur. J. Pharmacol. 396, 141-149.
44. Chuchawankul, S., Shima, M., Buckley, N. E., Hartmann, C. B., McCoy, K. L. (2004) Role of cannabinoid receptors in inhibiting macrophage costimulatory activity. Int. Immunopharmacol. 4, 265-278.
45. Clements, D. J., Matveyeva, M., McCoy, K. L. (1998) {increment}9-Tetrahydrocannabinol suppresses macrophage costimulation by decreasing heat-stable antigen expression. Int. J. Immunopharmacol. 20, 415-428.
46. Wacnik, P. W., Luhr, K. M., Hill, R. H., Ljunggren, H. G., Kristensson, K., Svensson, M. (2008) Cannabinoids affect dendritic cell (DC) potassium channel function and modulate DC T cell stimulatory capacity. J. Immunol. 181, 3057-3066.
47. Baskin, C. R., Bielefeldt-Ohmann, H., Tumpey, T. M., Sabourin, P. J., Long, J. P., Garcia-Sastre, A., Tolnay, A. E., Albrecht, R., Pyles, J. A., Olson, P. H., Aicher, L. D., Rosenzweig, E. R., Murali-Krishna, K., Clark, E. A., Kotur, M. S., Fornek, J. L., Proll, S., Palermo, R. E., Sabourin, C. L., Katze, M. G. (2009) Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc. Natl. Acad. Sci. USA 106, 3455-3460.
48. Brydon, E. W., Morris, S. J., Sweet, C. (2005) Role of apoptosis and cytokines in influenza virus morbidity. FEMS Microbiol. Rev. 29, 837-850.
49. Buchweitz, J. P., Harkema, J. R., Kaminski, N. E. (2007) Time-dependent airway epithelial and inflammatory cell responses induced by influenza virus A/PR/8/34 in C57BL/6 mice. Toxicol. Pathol. 35, 424-435.
50. Storr, M., Emmerdinger, D., Diegelmann, J., Pfennig, S., Ochsenkuhn, T., Goke, B., Lohse, P., Brand, S. (2010) The cannabinoid 1 receptor (CNR1) 1359 G/A polymorphism modulates susceptibility to ulcerative colitis and the phenotype in Crohn's disease. PLoS ONE 5, e9453.
51. Sipe, J. C., Arbour, N., Gerber, A., Beutler, E. (2005) Reduced endocannabinoid immune modulation by a common cannabinoid 2 (CB2) receptor gene polymorphism: possible risk for autoimmune disorders. J. Leukoc. Biol. 78, 231-238.
52. Middel, P., Raddatz, D., Gunawan, B., Haller, F., Radzun, H. J. (2006) Increased number of mature dendritic cells in Crohn's disease: evidence for a chemokine mediated retention mechanism. Gut 55, 220-227.
53. Serafini, B., Columba-Cabezas, S., Di Rosa, F., Aloisi, F. (2000) Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis. Am. J. Pathol. 157, 1991-2002.
54. Ludewig, B., Odermatt, B., Landmann, S., Hengartner, H., Zinkernagel, R. M. (1998) Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue. J. Exp. Med. 188, 1493-1501.